Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 20, 2026 16:08 ET | Source: Robbins LLP

Robbins LLP Reminds GOSS Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action Against Gossamer Bio, Inc.

Robbins LLP is Investigating Allegations that Gossamer Bio, Inc. (GOSS) Misled Investors Regarding the Viability of its PROSERA Study
May 18, 2026 08:00 ET | Source: Syneos Health, Inc.

Syneos Health Wins “Best Mobile App for Patient Engagement” in 2026 MedTech Breakthrough Awards

MORRISVILLE, N.C., May 18, 2026 (GLOBE NEWSWIRE) -- Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, has been announced as the “Best Mobile App for Patient...
May 14, 2026 09:00 ET | Source: Syneos Health, Inc.

Syneos Health Expands Strategic AI Partnerships to Advance Commercial Precision Performance

MORRISVILLE, N.C., May 14, 2026 (GLOBE NEWSWIRE) -- Syneos Health® today announced new and expanded strategic partnerships that strengthen its cutting-edge, AI ecosystem. These innovative solutions...
April 20, 2026 16:32 ET | Source: Robbins LLP

ADLX Stockholders Have Rights – If You Lost Money Investing in Aldeyra Therapeutics, Inc. Contact Robbins LLP for Information About Recovering Your Losses

Robbins LLP is Investigating Allegations that Aldeyra Therapeutics, Inc. (ALDX) Misled Investors Regarding its Lead Drug Candidate
April 06, 2026 13:17 ET | Source: Robbins LLP

GOSS Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Gossamer Bio, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Gossamer Bio, Inc. (GOSS) Misled Investors Regarding the Viability of its PROSERA Study
April 06, 2026 08:30 ET | Source: Nightfood Holdings Inc.

Nightfood Holdings, Inc. (dba TechForce Robotics) Announces Strategic Joint Development Agreement with Oncotelic Therapeutics

TEMECULA, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- via IBN – Nightfood Holdings, Inc., (OTCQB: NGTF) doing business as TechForce Robotics, Inc., (“TechForce” or the “Company”), today announced the...
March 11, 2026 20:19 ET | Source: Robbins LLP

Nektar Therapeutics Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the NKTR Securities Class Action

Robbins LLP is Investigating Allegations that Nektar Therapeutics (NKTR) Overstated the Prospects of its REZOLVE-AA Trial
February 09, 2026 16:16 ET | Source: Robbins LLP

MREO Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Mereo BioPharma Group plc Class Action

Robbins LLP is Investigating Allegations that Mereo BioPharma Group plc (MREO) Misled Investors Regarding Phase 3 Orbit and Cosmic Studies for Setrusumab
January 20, 2026 16:30 ET | Source: Robbins LLP

VTGN Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Vistagen Therapeutics, Inc. Securities Class Action Lawsuit

Robbins LLP is Investigating Allegations that Vistagen Therapeutics, Inc. (VTGN) Misled Investors Regarding the Viability of its Trial Study of Fasedienol
November 18, 2025 14:26 ET | Source: Robbins LLP

SKYE Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Against Skye Bioscience, Inc.

Robbins LLP is Investigating Allegations that Skye Bioscience, Inc. (SKYE) Misled Investors Regarding the Viability of its Lead Drug Candidate